ARCHIVES

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

This article is from The Cancer Letter archive.

Vol. 30 No. 39 | October 15, 2004

Download PDF Visit The Full Archive

Related Articles

Cancer Patient Medical history System Proposed

July 13, 1979

NCI “Month” Appropriate For May, With Several Major Decisions Pending got Start Next 50 Years

May 1, 1987

Funding Opportunity: Stand Up To Cancer Canada to Fund Two Dream Teams

October 17, 2014

New Missouri Center Seeing a Director

July 16, 1982

In Brief: Senate Bill Would Give NCI $1.034 Billion In 1982, $45 Million (3.5 Percent) More Than FY 1981 Budget

September 25, 1981

Treatment Division Outlines Future Program Areas

January 24, 1975